Literature DB >> 25050057

Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal.

Philip J Gregory, Chris Fellner.   

Abstract

An array of natural substances purported to possess disease-modifying qualities for osteoarthritis are designated as "dietary supplements" and thus avoid rigorous FDA regulation. Substantial scientific evidence for the efficacy of these agents is elusive.

Entities:  

Year:  2014        PMID： 25050057      PMCID： PMC4103717     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  86 in total

Review 1.  Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.

Authors:  I Setnikar; L C Rovati
Journal:  Arzneimittelforschung       Date:  2001-09

2.  [A multi-central, randomized, controlled clinical trial of glucosamine hydrochloride/sulfate in the treatment of knee osteoarthritis].

Authors:  Gui-xing Qiu; Xi-sheng Weng; Ke Zhang; Yi-xiong Zhou; Si-quan Lou; Yi-peng Wang; Wei Li; Hong Zhang; Yan Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-11-16

3.  North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-08-22

4.  Glucosamine and osteoarthritis: time to quit?

Authors:  Ranganath Muniyappa
Journal:  Diabetes Metab Res Rev       Date:  2011-03       Impact factor: 4.876

Review 5.  Glucosamine in osteoarthritis: questions remain.

Authors:  Carlos J Lozada
Journal:  Cleve Clin J Med       Date:  2007-01       Impact factor: 2.321

Review 6.  The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis: are these saccharides drugs or nutraceuticals?

Authors:  Vilím Simánek; Vladimír Kren; Jitka Ulrichová; Jirí Gallo
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2005-06       Impact factor: 1.245

Review 7.  Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.

Authors:  C L Deal; R W Moskowitz
Journal:  Rheum Dis Clin North Am       Date:  1999-05       Impact factor: 2.670

8.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

9.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

10.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245
View more
  2 in total

Review 1.  Re-appraising the potential of naringin for natural, novel orthopedic biotherapies.

Authors:  Kristin E Yu; Kareme D Alder; Montana T Morris; Alana M Munger; Inkyu Lee; Sean V Cahill; Hyuk-Kwon Kwon; JungHo Back; Francis Y Lee
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-08       Impact factor: 5.346

Review 2.  A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?

Authors:  Ursule Kalvaityte; Ilona Uzieliene; Christina E Larder; Michèle M Iskandar; Ali Mobasheri; Armaghan Mahmoudian; Stan Kubow; Paulo Cesar Hamdan; Cyro Scala de Almeida; Lacey J Favazzo; Luc J C van Loon; Pieter J Emans; Pérola G Plapler; Michael J Zuscik
Journal:  Curr Rheumatol Rep       Date:  2021-10-30       Impact factor: 4.686
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.